These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 4651413

  • 1. [Study, by means of a spectrofluorometric method, of plasma concentrations of doxycycline and of the elimination of this antibiotic in urine or dialysis fluid in patients with severe chronic kidney failure].
    Gavend M, Muller JM, Bessard G, Meftahi H, Debru JL, Cordonnier D.
    Therapie; 1972; 27(5):925-36. PubMed ID: 4651413
    [No Abstract] [Full Text] [Related]

  • 2. Doxycycline: studies in normal subjects and patients with renal failure.
    Lee P, Crutch ER, Morrison RB.
    N Z Med J; 1972 Jun; 75(481):355-8. PubMed ID: 4564509
    [No Abstract] [Full Text] [Related]

  • 3. The elimination of tritiated doxycycline in normal subjects and in patients with severely impaired renal function.
    Mahon WA, Johnson GE, Endrenyl L, Kelly MF, Fenton SS.
    Scand J Infect Dis Suppl; 1976 Jun; (9):24-31. PubMed ID: 1070145
    [Abstract] [Full Text] [Related]

  • 4. Doxycycline (Vibramycin) in chronic renal failure.
    Letteri JM, Miraflor F, Tablante V, Siddiqi S.
    Nephron; 1973 Jun; 11(5):318-24. PubMed ID: 4584946
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Doxycycline (Vibramycin) in renal failure].
    Stenbaek O, Myhre E, Berdal BP.
    Tidsskr Nor Laegeforen; 1974 Dec 10; 94(34-36):2388-9. PubMed ID: 4614492
    [No Abstract] [Full Text] [Related]

  • 7. Preliminary studies on the elimination of 3-H doxycycline in normal subjects and in patients with severely impaired renal function.
    Mahon WA, Johnson GE, Kelly MF, Fenton SS.
    Rev Can Biol; 1973 Dec 10; 32():Suppl:107-11. PubMed ID: 4777591
    [No Abstract] [Full Text] [Related]

  • 8. [Study of renal function in renal insufficiency. I. Renal function of the patients under chronic hemodialysis].
    Kawamura J, Okabe T, Yamashita A, Sawanishi K, Katõ T.
    Hinyokika Kiyo; 1971 Mar 10; 17(3):157-86. PubMed ID: 5103947
    [No Abstract] [Full Text] [Related]

  • 9. Evaluation of toxic metals in blood and urine samples of chronic renal failure patients, before and after dialysis.
    Kazi TG, Jalbani N, Kazi N, Jamali MK, Arain MB, Afridi HI, Kandhro A, Pirzado Z.
    Ren Fail; 2008 Mar 10; 30(7):737-45. PubMed ID: 18704823
    [Abstract] [Full Text] [Related]

  • 10. Heparin elimination and hemostasis in hemodialysis.
    Wilhelmsson S, Lins LE.
    Clin Nephrol; 1984 Dec 10; 22(6):303-6. PubMed ID: 6525772
    [Abstract] [Full Text] [Related]

  • 11. Garenoxacin pharmacokinetics in subjects with renal impairment.
    Krishna G, Gajjar D, Swan S, Marbury T, Grasela DM, Wang Z.
    Curr Med Res Opin; 2007 Mar 10; 23(3):649-57. PubMed ID: 17355746
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Parenteral administration of a new cephalosporin in patients with chronic kidney failure. Study of plasmatic half-life of the antibiotic in relation to glomerular clearance].
    Malandain H, Humbert G, Fillastre JP, Acar J, Dubois D, Leroy J, Robert M, Daufresne MF.
    Pathol Biol (Paris); 1973 Mar 10; 21(3):233-9. PubMed ID: 4574486
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Serum concentration and urinary excretion of doxycline in normal subjects and patients with renal insufficiency.
    Ao NK, Taneja OP, Bhatia VN, Aggarwal DS.
    Chemotherapy; 1974 Mar 10; 20(3):129-40. PubMed ID: 4854258
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Doxycycline (Vibramycin) in restricted renal function].
    Porpáczy P.
    Wien Klin Wochenschr; 1970 Oct 09; 82(41):710-4. PubMed ID: 5480598
    [No Abstract] [Full Text] [Related]

  • 18. Endothelial dysfunction in patients with kidney failure and vascular risk factors: acute effects of hemodialysis.
    Migliacci R, Falcinelli F, Imperiali P, Floridi A, Nenci GG, Gresele P.
    Ital Heart J; 2004 May 09; 5(5):371-7. PubMed ID: 15185901
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Urinary excretion of rifampicin in kidney failure when administered alone or together with isoniazid].
    Titarenko OT, Vakhmistrova TI, Perova TL.
    Antibiotiki; 1983 Sep 09; 28(9):698-702. PubMed ID: 6638984
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.